Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPS-102 for Scalp Psoriasis
NCT01368887Phase 2Suspended
- Sponsor
- DermiPsor Ltd.
- Start
- Apr 2013
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcipotriol, nicotinamide in psoriasis, sponsored by DermiPsor Ltd.. Started Apr 2013; status: suspended.
02
Drugs
calcipotriolnicotinamide
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01368887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368887.